↓ Skip to main content

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

Overview of attention for article published in Frontiers in immunology, June 2019
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Published in
Frontiers in immunology, June 2019
DOI 10.3389/fimmu.2019.01151
Pubmed ID
Authors

Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, Yolanda Aguilera, Lucía Llanos, Juan R. Tejedo, Francisco J. Bedoya, Verónica Juan, Antonio De la Cuesta, Rafael Ruiz-Salmerón, Enrique Andreu, Lukas Grochowicz, Felipe Prósper, Fermín Sánchez-Guijo, Francisco S. Lozano, Manuel Miralles, Lourdes Del Río-Solá, Gregorio Castellanos, José M. Moraleda, Robert Sackstein, Mariano García-Arranz, Damián García-Olmo, Franz Martín, Abdelkrim Hmadcha, Bernat Soria, Collaborative Working Group “Noma Project Team”

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 92 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 24%
Researcher 9 10%
Student > Ph. D. Student 7 8%
Other 7 8%
Student > Postgraduate 6 7%
Other 19 21%
Unknown 22 24%
Readers by discipline Count As %
Medicine and Dentistry 25 27%
Biochemistry, Genetics and Molecular Biology 18 20%
Agricultural and Biological Sciences 7 8%
Engineering 6 7%
Immunology and Microbiology 4 4%
Other 9 10%
Unknown 23 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2021.
All research outputs
#17,604,528
of 25,806,080 outputs
Outputs from Frontiers in immunology
#20,745
of 32,415 outputs
Outputs of similar age
#234,160
of 368,041 outputs
Outputs of similar age from Frontiers in immunology
#480
of 706 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,415 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,041 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 706 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.